Summary
Chick cerebral β-adrenoceptors have been characterised by measurement of cyclic AMP accumulation in brain slices and assessment of the specific binding of [3H]-propranolol to cerebral membranes. The binding of [3H]-propranolol was inhibited by β-adrenoceptor agonists and antagonists with affinities that correlated well with their ability to stimulate cyclic AMP formation or to antagonise the cyclic nucleotide accumulation induced by isoprenaline. The relative potencies of a number of drugs in several cerebral regions suggests that the receptors may be of the β2 subtype. Regional distribution studies revealed the highest density of binding sites in the cerebellum and lowest in the optic lobes. However, the concentration of [3H]-propranolol that produced half-maximal specific binding was similar in all regions. Subcellular fractionation of cerebral hemisphere tissue demonstrated an enrichment of [3H]-propranolol binding sites in the synaptosomal and microsomal fractions. There are discrepancies between the topographical distribution of β-adrenoceptor binding sites and the endogenous noradrenaline level in chick brain and between the number of binding sites and the intrinsic activity of β-adrenoceptor mediated cyclic AMP formation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Åblad, B., Carlsson, E., Ek, L.: Pharmacological studies of two new cardioselective adrenergic beta receptor antagonists. Life Sci. 12, 107–119 (1973)
Alexander, R. W., Davis, J. N., Lefkowitz, R. J.: Direct identification and characterization of β-adrenergic receptors in rat brain. Nature (Lond.) 258, 437–440 (1975)
Barrett, A. M., Carter, J., Fitzgerald, J. D., Hull, R., Le Court, D.: A new type of cardioselective adrenoceptive blocking drug. Brit. J. Pharmacol. 48, 340 (1973)
Bilezikian, J. P., Aurbach, G. D.: The effects of nucleotides on the expression of β-adrenergic adenylate cyclase in membranes from turkey erythrocytes. J. biol. Chem. 249, 157–161 (1974)
Bloom, F. E.: Amine receptors in CNS 1. Norepinephrine. In: Handbook of Psychopharmacology, Vol. 6 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), pp. 1–18. New York: Plenum Press 1975
Brown, B. L., Albano, J. D. M., Eskins, R. P., Ssherzi, A. M.: A simple and sensitive staturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphate. Biochem. J. 121, 561–562 (1971)
Brown, E. M., Fedak, S. A., Woodard, C. J., Aurbach, G. D.: β-Adrenergic receptor interactions. J. biol. Chem. 251, 1239–1246 (1976)
Bylund, D. B., Snyder, S. H.: β-Adrenergic receptor binding in membrane preparations from mammalian brain. Molec. Pharmacol. 12, 568–580 (1976)
Daly, J.: Role of cyclic nucleotides in the nervous system. In: Handbook of Psychopharmacology, Vol. 6 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), pp. 47–131. New York: Plenum Press 1975
Dunlop, D., Shanks, R. G.: Selective blockade of adrenoceptor beta receptors in the heart. Brit. J. Pharmacol. 32, 201–218 (1968)
Farmer, J. B., Kennedy, I., Levy, G. P., Marshall, R. J.: A comparison of the β-adrenoceptor stimulant properties of isoprenaline with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guineapig. J. Pharm. Pharmacol. 22, 61–63 (1970)
Gilman, A. G., Nirenberg, M.: Effect of catecholamines on the adenosine 3′,5′-cyclic monophosphate concentrations of clonal satellite cells of neurons. Proc. nat. Acad. Sci. (Wash.) 68, 2165–2168 (1971)
Gilman, A. G., Schrier, B. K.: Adenosine cyclic 3′,5′-monophosphate in foetal rat brain cell cultures. 1. Effect of catecholamines. Molec. Pharmacol. 8, 410–416 (1972)
Harwood, J. P., Low, H., Rodbell, M.: Stimulatory and inhibitory effects of guanyl nucleotides on fat cell adenylate cyclase. J. biol. Chem. 248, 6239–6245 (1973)
Henn, F. A., Anderson, D. J., Rustael, D. G.: Glial contamination of synaptosomal fraction. Brain Res. 101, 341–344 (1976)
Horn, A. S., Phillipson, O. T.: A noradrenaline sensitive adenylate cyclase in rat limbic forebrain, preparation, properties and the effects of agonists adrenolytics and neuroleptic drugs. Europ. J. Pharmacol. 37, 1–11 (1976)
Jurio, A. V., Vogt, M.: Monoamines and metabolites in the avian brain. J. Physiol. (Lond.) 189, 489 (1967)
Lands, A. M., Arnold, A., McAuliff, J. P., Luduena, F. P., Brown, T. G.: Differentiation of receptor system activated by sympathomimetic amines. Nature (Lond.) 214, 597–598 (1967)
Lefkowitz, R. J., Mukherjee, C., Coverstone, M., Caron, M.: Stereospecific [3H] (-)alprenolol binding sites, β-adrenergic receptors and adenylate cyclase. Biochem. biophys. Res. Commun. 60, 703–709 (1974)
Lefkowitz, R. J., Mullikin, D., Caron, M. G.: Regulation of β-adrenergic receptors by guanyl-5′-ylimidodiphosphate and other purine nucleotides. J. biol. Chem. 251, 4686–4692 (1976)
Levitzki, A., Atlas, D., Steer, M. L.: The binding characteristics and number of β-adrenergic receptors on the turkey erythrocyte. Proc. nat. Acad. Sci. (Wash.) 71, 2773–2776 (1974)
Levy, B., Wilkenfeld, B. E.: An analysis of selective beta receptor blockade. Europ. J. Pharmacol. 5, 227–234 (1969)
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurements with the folin phenol reagent. J. biol. Chem. 193, 265–275 (1951)
Maguire, M. E., Wikland, R. A., Anderson, H. J., Gilman, A. G.: Binding of [125I]hydroxybenzylpindolol to putative β-adrenergic receptors of rat glioma cells and other cell clones. J. biol. Chem. 251, 1221–1231 (1976)
Nahorski, S. R.: Association of high affinity stereospecific binding of [3H]-propranolol to cerebral membranes with β-adrenoceptors. Nature (Lond.) 259, 488–489 (1976)
Nahorski, S. R., Rogers, K. J.: Altered sensitivity of β-adrenoceptor-mediated cyclic AMP formation in brain. Brit. J. Pharmacol. 55, 300–301 (1975)
Nahorski, S. R., Smith, B. M.: Stimulated formation of cyclic AMP in different areas of chick brain. Europ. J. Pharmacol. 40, 273–278 (1976)
Nahorski, S. R., Rogers, K. J., Smith, B. M., Anson, J.: Characterisation of the adrenoceptor mediating changes in cyclic adenosine 3′,5′-monophosphate in chick cerebral hemispheres. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 101 (1975a)
Nahorski, S. R., Rogers, K. J., Edwards, C.: Cerebral glycogenolysis and stimulation of β-adrenoceptors and histamine H2 receptors. Brain Res. 92, 529–533 (1975b)
Perkins, J. P., Moore, M. M.: Characterisation of the adrenergic receptors mediating a rise in cyclic 3′,5′-adenosine monophosphate in rat cerebral cortex. J. Pharmacol. exp. Ther. 185, 371–378 (1973)
Petrack, B., Czernik, A. J.: Inhibition of isoproterenol activation of adenylate cyclase by metoprolol. oxprenolol and the para isomer of oxprenolol. Molec. Pharmacol. 12, 203–207 (1976)
Robison, G. A., Butcher, R. W., Sutherland, E. W.: Cyclic AMP. New York: Academic Press 1971
Sporn, J. R., Molinoff, P. B.: β-Adrenergic receptors in rat brain. J. Cycl. Nucl. Res. 2, 149–161 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nahorski, S.R., Smith, B.M. Characteristics of chick cerebral β-adrenoceptors assessed by cyclic adenosine 3′,5′ monophosphate formation and [3H]-propranolol binding. Naunyn-Schmiedeberg's Arch. Pharmacol. 298, 23–28 (1977). https://doi.org/10.1007/BF00510982
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00510982